Abstract
Evidence is increasing that chemical exposure significantly contributes to human ill health. This chapter focuses on endocrine disrupting chemicals (EDCs), a group of substances that interfere with our endogenous hormonal system. Exposure to EDCs, in particular during pre- and early postnatal development, has been associated with a number of disorders such as decreased fertility, hormone-related cancers, as well as neurodevelopmental and metabolic disorders. EDCs differ from classical toxicants in several ways, they can for example affect the organism already at very low doses and introduce long-term changes that manifest much later in life. Such effects could be mediated by epigenetic changes. Indeed, a large number of experimental studies have shown that EDCs can induce epigenetic changes, in particular alteration in DNA methylation. This is corroborated by some epidemiological studies where epigenetic changes were linked to EDC exposure. In this chapter, we introduce examples of EDCs, their exposure sources and modes of actions, and summarize the evidence for their effects on the epigenome in relation to their impact on fertility, neurodevelopment, and metabolism.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
The European Chemical Industry Council (cefic), Facts and Figures 2017. 2017.
OECD. OECD environmental outlook to 2050: the consequences of inaction. Paris: OECD Publishing; 2012.
Grandjean P, Landrigan PJ. Developmental neurotoxicity of industrial chemicals. Lancet. 2006;368(9553):2167–78.
Geyer R, Jambeck JR, Law KL. Production, use, and fate of all plastics ever made. Sci Adv. 2017;3(7):e1700782.
Yang C, et al. Persistent organic pollutants as risk factors for obesity and diabetes. Curr Diab Rep. 2017;17(12):132.
Mallozzi M, et al. The effect of maternal exposure to endocrine disrupting chemicals on fetal and neonatal development: a review on the major concerns. Birth Defects Res C Embryo Today. 2016;108(3):224–42.
Zoeller RT, et al. A path forward in the debate over health impacts of endocrine disrupting chemicals. Environ Health. 2014;13:118.
Zoeller RT, et al. Endocrine-disrupting chemicals and public health protection: a statement of principles from the Endocrine Society. Endocrinology. 2012;153(9):4097–110.
WHO/UNEP, State of the science of endocrine disrupting chemicals – 2012. 2013.
Vandenberg LN, et al. Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocr Rev. 2012;33(3):378–455.
Rudel RA, Perovich LJ. Endocrine disrupting chemicals in indoor and outdoor air. Atmos Environ (1994), 2009. 43(1): p. 170–181.
Weiss JM, et al. Daily intake of phthalates, MEHP, and DINCH by ingestion and inhalation. Chemosphere. 2018;208:40–9.
Koch HM, et al. Identifying sources of phthalate exposure with human biomonitoring: results of a 48h fasting study with urine collection and personal activity patterns. Int J Hyg Environ Health. 2013;216(6):672–81.
Lopez-Cervantes J, Paseiro-Losada P. Determination of bisphenol A in, and its migration from, PVC stretch film used for food packaging. Food Addit Contam. 2003;20(6):596–606.
Hu XC, et al. Detection of poly- and Perfluoroalkyl Substances (PFASs) in U.S. drinking water linked to industrial sites, military fire training areas, and wastewater treatment plants. Environ Sci Technol Lett. 2016;3(10):344–50.
Faniband M, Lindh CH, Jonsson BA. Human biological monitoring of suspected endocrine-disrupting compounds. Asian J Androl. 2014;16(1):5–16.
Woodruff TJ, Zota AR, Schwartz JM. Environmental chemicals in pregnant women in the United States: NHANES 2003-2004. Environ Health Perspect. 2011;119(6):878–85.
Kortenkamp A. Ten years of mixing cocktails: a review of combination effects of endocrine-disrupting chemicals. Environ Health Perspect. 2007;115(Suppl 1):98–105.
Ramhoj L, et al. Perfluorohexane Sulfonate (PFHxS) and a mixture of endocrine disrupters reduce thyroxine levels and cause anti-androgenic effects in rats. Toxicol Sci. 2018;163:579–91.
Bergman A, et al. The impact of endocrine disruption: a consensus statement on the state of the science. Environ Health Perspect. 2013;121(4):A104–6.
Shu H, et al. Temporal trends of phthalate exposures during 2007-2010 in Swedish pregnant women. J Expo Sci Environ Epidemiol. 2018;28:437–47.
Sarcinelli PN, et al. Dietary and reproductive determinants of plasma organochlorine levels in pregnant women in Rio de Janeiro. Environ Res. 2003;91(3):143–50.
Vuong AM, et al. Maternal Polybrominated Diphenyl Ether (PBDE) exposure and thyroid hormones in maternal and cord sera: the HOME study, Cincinnati, USA. Environ Health Perspect. 2015;123(10):1079–85.
Needham LL, et al. Partition of environmental chemicals between maternal and fetal blood and tissues. Environ Sci Technol. 2011;45(3):1121–6.
Gutzkow KB, et al. Placental transfer of perfluorinated compounds is selective—a Norwegian mother and child sub-cohort study. Int J Hyg Environ Health. 2012;215(2):216–9.
Mazdai A, et al. Polybrominated diphenyl ethers in maternal and fetal blood samples. Environ Health Perspect. 2003;111(9):1249–52.
Guvenius DM, et al. Human prenatal and postnatal exposure to polybrominated diphenyl ethers, polychlorinated biphenyls, polychlorobiphenylols, and pentachlorophenol. Environ Health Perspect. 2003;111(9):1235–41.
Inoue K, et al. Perfluorooctane sulfonate (PFOS) and related perfluorinated compounds in human maternal and cord blood samples: assessment of PFOS exposure in a susceptible population during pregnancy. Environ Health Perspect. 2004;112(11):1204–7.
Schecter A, Kassis I, Papke O. Partitioning of dioxins, dibenzofurans, and coplanar PCBS in blood, milk, adipose tissue, placenta and cord blood from five American women. Chemosphere. 1998;37(9–12):1817–23.
Group EW. Body burden: the pollution in newborns. 2005.
Janesick AS, Blumberg B. Obesogens: an emerging threat to public health. Am J Obstet Gynecol. 2016;214(5):559–65.
Crain DA, et al. Female reproductive disorders: the roles of endocrine-disrupting compounds and developmental timing. Fertil Steril. 2008; 90(4):911–40.
Grandjean P, Landrigan PJ. Neurobehavioural effects of developmental toxicity. Lancet Neurol. 2014;13(3):330–8.
Rice D, Barone S Jr. Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. Environ Health Perspect. 2000;108(Suppl 3):511–33.
Bale TL, et al. Early life programming and neurodevelopmental disorders. Biol Psychiatry. 2010;68(4):314–9.
Barker DJ. The origins of the developmental origins theory. J Intern Med. 2007;261(5):412–7.
Gluckman PD, Hanson MA. Living with the past: evolution, development, and patterns of disease. Science. 2004;305(5691):1733–6.
Jacobs MN, et al. Marked for life: epigenetic effects of endocrine disrupting chemicals. Annu Rev Environ Resour. 2017;42:105–60.
Bird A. DNA methylation patterns and epigenetic memory. Genes Dev. 2002;16(1):6–21.
Skinner MK, Manikkam M, Guerrero-Bosagna C. Epigenetic transgenerational actions of environmental factors in disease etiology. Trends Endocrinol Metab. 2010;21(4):214–22.
Marczylo EL, Jacobs MN, Gant TW. Environmentally induced epigenetic toxicity: potential public health concerns. Crit Rev Toxicol. 2016;46(8):676–700.
Tran NQV, Miyake K. Neurodevelopmental disorders and environmental toxicants: epigenetics as an underlying mechanism. Int J Genomics. 2017;2017:7526592.
Walker DM, Gore AC. Epigenetic impacts of endocrine disruptors in the brain. Front Neuroendocrinol. 2017;44:1–26.
Alavian-Ghavanini A, Ruegg J. Understanding epigenetic effects of endocrine disrupting chemicals: from mechanisms to novel test methods. Basic Clin Pharmacol Toxicol. 2018;122(1):38–45.
Manikkam M, et al. Plastics derived endocrine disruptors (BPA, DEHP and DBP) induce epigenetic transgenerational inheritance of obesity, reproductive disease and sperm epimutations. PLoS One. 2013;8(1):e55387.
Wolstenholme JT, Goldsby JA, Rissman EF. Transgenerational effects of prenatal bisphenol A on social recognition. Horm Behav. 2013;64(5):833–9.
Anway MD, et al. Epigenetic transgenerational actions of endocrine disruptors and male fertility. Science. 2005;308(5727):1466–9.
Titus-Ernstoff L, et al. Menstrual and reproductive characteristics of women whose mothers were exposed in utero to diethylstilbestrol (DES). Int J Epidemiol. 2006;35(4):862–8.
Bellinger DC. A strategy for comparing the contributions of environmental chemicals and other risk factors to neurodevelopment of children. Environ Health Perspect. 2012;120(4):501–7.
Landrigan PJ, et al. The Lancet Commission on pollution and health. Lancet. 2018;391(10119):462–512.
Levine H, et al. Temporal trends in sperm count: a systematic review and meta-regression analysis. Hum Reprod Update. 2017;23(6):646–59.
Hamilton BE, Ventura SJ. Fertility and abortion rates in the United States, 1960-2002. Int J Androl. 2006;29(1):34–45.
Lassen TH, et al. Trends in rates of natural conceptions among Danish women born during 1960–1984. Hum Reprod. 2012;27(9):2815–22.
Vander Borght M, Wyns C. Fertility and infertility: definition and epidemiology. Clin Biochem. 2018;62:2–10.
Sharma R, et al. Lifestyle factors and reproductive health: taking control of your fertility. Reprod Biol Endocrinol. 2013;11:66.
Fowler PA, et al. Impact of endocrine-disrupting compounds (EDCs) on female reproductive health. Mol Cell Endocrinol. 2012;355(2):231–9.
Ho SM, et al. Environmental factors, epigenetics, and developmental origin of reproductive disorders. Reprod Toxicol. 2017;68:85–104.
Al Jishi T, Sergi C. Current perspective of diethylstilbestrol (DES) exposure in mothers and offspring. Reprod Toxicol. 2017;71:71–7.
Palmer JR, et al. Infertility among women exposed prenatally to diethylstilbestrol. Am J Epidemiol. 2001;154(4):316–21.
Kaufman RH, et al. Continued follow-up of pregnancy outcomes in diethylstilbestrol-exposed offspring. Obstet Gynecol. 2000;96(4):483–9.
Signorile PG, et al. Pre-natal exposure of mice to bisphenol A elicits an endometriosis-like phenotype in female offspring. Gen Comp Endocrinol. 2010;168(3):318–25.
Ziv-Gal A, et al. The effects of in utero bisphenol A exposure on reproductive capacity in several generations of mice. Toxicol Appl Pharmacol. 2015;284(3):354–62.
Wilcox AJ, et al. Fertility in men exposed prenatally to diethylstilbestrol. N Engl J Med. 1995;332(21):1411–6.
Palmer JR, et al. Urogenital abnormalities in men exposed to diethylstilbestrol in utero: a cohort study. Environ Health. 2009;8:37.
Eisenberg ML, et al. The relationship between anogenital distance, fatherhood, and fertility in adult men. PLoS One. 2011;6(5):e18973.
Mendiola J, et al. Shorter anogenital distance predicts poorer semen quality in young men in Rochester, New York. Environ Health Perspect. 2011;119(7):958–63.
Swan SH, et al. First trimester phthalate exposure and anogenital distance in newborns. Hum Reprod. 2015;30(4):963–72.
Bornehag CG, et al. Prenatal phthalate exposures and anogenital distance in Swedish boys. Environ Health Perspect. 2015;123(1):101–7.
Swan SH, et al. Decrease in anogenital distance among male infants with prenatal phthalate exposure. Environ Health Perspect. 2005;113(8):1056–61.
Bustamante-Montes LP, et al. Prenatal exposure to phthalates is associated with decreased anogenital distance and penile size in male newborns. J Dev Orig Health Dis. 2013;4(4):300–6.
Wenzel AG, et al. Influence of race on prenatal phthalate exposure and anogenital measurements among boys and girls. Environ Int. 2018;110:61–70.
Gray LE Jr, et al. Perinatal exposure to the phthalates DEHP, BBP, and DINP, but not DEP, DMP, or DOTP, alters sexual differentiation of the male rat. Toxicol Sci. 2000;58(2):350–65.
Macleod DJ, et al. Androgen action in the masculinization programming window and development of male reproductive organs. Int J Androl. 2010;33(2):279–87.
Foster PM. Disruption of reproductive development in male rat offspring following in utero exposure to phthalate esters. Int J Androl, 2006. 29(1): 140–147; discussion 181-5.
Vogel SA. The politics of plastics: the making and unmaking of bisphenol a “safety”. Am J Public Health. 2009;99(Suppl 3):S559–66.
Nakamura T, et al. Estrogen receptor subtypes selectively mediate female mouse reproductive abnormalities induced by neonatal exposure to estrogenic chemicals. Toxicology. 2008;253(1–3):117–24.
Couse JF, Korach KS. Estrogen receptor-alpha mediates the detrimental effects of neonatal diethylstilbestrol (DES) exposure in the murine reproductive tract. Toxicology. 2004;205(1–2):55–63.
Mahoney MM, Padmanabhan V. Developmental programming: impact of fetal exposure to endocrine-disrupting chemicals on gonadotropin-releasing hormone and estrogen receptor mRNA in sheep hypothalamus. Toxicol Appl Pharmacol. 2010;247(2):98–104.
Kundakovic M, et al. Sex-specific epigenetic disruption and behavioral changes following low-dose in utero bisphenol a exposure. Proc Natl Acad Sci USA. 2013;110(24):9956–61.
Wise LA, et al. Prenatal diethylstilbestrol exposure and reproductive hormones in premenopausal women. J Dev Orig Health Dis. 2015;6(3):208–16.
Lee BM, Koo HJ. Hershberger assay for antiandrogenic effects of phthalates. J Toxicol Environ Health A. 2007;70(15–16):1365–70.
Wilson VS, et al. Phthalate ester-induced gubernacular lesions are associated with reduced insl3 gene expression in the fetal rat testis. Toxicol Lett. 2004;146(3):207–15.
Wu S, et al. Dynamic effect of di-2-(ethylhexyl) phthalate on testicular toxicity: epigenetic changes and their impact on gene expression. Int J Toxicol. 2010;29(2):193–200.
Welsh M, et al. Identification in rats of a programming window for reproductive tract masculinization, disruption of which leads to hypospadias and cryptorchidism. J Clin Invest. 2008;118(4):1479–90.
Martino-Andrade AJ, et al. Timing of prenatal phthalate exposure in relation to genital endpoints in male newborns. Andrology. 2016;4(4):585–93.
Gray LE Jr et al. Adverse effects of environmental antiandrogens and androgens on reproductive development in mammals. Int J Androl, 2006. 29(1): 96–104; discussion 105–8.
Newschaffer CJ, Falb MD, Gurney JG. National autism prevalence trends from United States special education data. Pediatrics. 2005;115(3):e277–82.
Hertz-Picciotto I, Delwiche L. The rise in autism and the role of age at diagnosis. Epidemiology. 2009;20(1):84–90.
(EPA), U.S.E.P.A., America’s children and the environment. 2013.
McDonald ME, Paul JF. Timing of increased autistic disorder cumulative incidence. Environ Sci Technol. 2010;44(6):2112–8.
Mojtabai R, Olfson M, Han B. National Trends in the prevalence and treatment of depression in adolescents and young adults. Pediatrics. 2016;138(6):e20161878.
Chan KY, et al. Prevalence of schizophrenia in China between 1990 and 2010. J Glob Health. 2015;5(1):010410.
Hallmayer J, et al. Genetic heritability and shared environmental factors among twin pairs with autism. Arch Gen Psychiatry. 2011;68(11):1095–102.
Sandin S, et al. THe familial risk of autism. JAMA. 2014;311(17):1770–7.
Rossignol DA, Genuis SJ, Frye RE. Environmental toxicants and autism spectrum disorders: a systematic review. Transl Psychiatry. 2014;4:e360.
Braun JM, et al. Impact of early-life bisphenol A exposure on behavior and executive function in children. Pediatrics. 2011;128(5):873–82.
Harley KG, et al. Prenatal and early childhood bisphenol A concentrations and behavior in school-aged children. Environ Res. 2013;126:43–50.
Evans SF, et al. Prenatal bisphenol A exposure and maternally reported behavior in boys and girls. Neurotoxicology. 2014;45:91–9.
Perera F, et al. Bisphenol A exposure and symptoms of anxiety and depression among inner city children at 10–12 years of age. Environ Res. 2016;151:195–202.
Braun JM, et al. Prenatal environmental chemical exposures and longitudinal patterns of child neurobehavior. Neurotoxicology. 2017;62:192–9.
Chen A, et al. Prenatal polybrominated diphenyl ether exposures and neurodevelopment in U.S. children through 5 years of age: the HOME study. Environ Health Perspect. 2014;122(8):856–62.
Eskenazi B, et al. In utero and childhood polybrominated diphenyl ether (PBDE) exposures and neurodevelopment in the CHAMACOS study. Environ Health Perspect. 2013;121(2):257–62.
Herbstman JB, et al. Prenatal exposure to PBDEs and neurodevelopment. Environ Health Perspect. 2010;118(5):712–9.
Sagiv SK, et al. Prenatal and childhood polybrominated diphenyl ether (PBDE) exposure and attention and executive function at 9–12 years of age. Neurotoxicol Teratol. 2015;52(Pt B):151–61.
Forns J, et al. Prenatal exposure to polychlorinated biphenyls and child neuropsychological development in 4-year-olds: an analysis per congener and specific cognitive domain. Sci Total Environ. 2012;432:338–43.
Sagiv SK, et al. Prenatal organochlorine exposure and behaviors associated with attention deficit hyperactivity disorder in school-aged children. Am J Epidemiol. 2010;171(5):593–601.
Stewart PW, et al. The relationship between prenatal PCB exposure and intelligence (IQ) in 9-year-old children. Environ Health Perspect. 2008;116(10):1416–22.
Kyriklaki A, et al. Prenatal exposure to persistent organic pollutants in association with offspring neuropsychological development at 4years of age: the Rhea mother-child cohort, Crete, Greece. Environ Int. 2016;97:204–11.
Kim S, et al. Association between maternal exposure to major phthalates, heavy metals, and persistent organic pollutants, and the neurodevelopmental performances of their children at 1 to 2years of age- CHECK cohort study. Sci Total Environ. 2018;624:377–84.
Arbuckle TE, et al. Bisphenol A, phthalates and lead and learning and behavioral problems in Canadian children 6–11 years of age: CHMS 2007–2009. Neurotoxicology. 2016;54:89–98.
Whyatt RM, et al. Maternal prenatal urinary phthalate metabolite concentrations and child mental, psychomotor, and behavioral development at 3 years of age. Environ Health Perspect. 2012;120(2):290–5.
Kobrosly RW, et al. Prenatal phthalate exposures and neurobehavioral development scores in boys and girls at 6–10 years of age. Environ Health Perspect. 2014;122(5):521–8.
Olesen TS, et al. Prenatal phthalate exposure and language development in toddlers from the Odense Child Cohort. Neurotoxicol Teratol. 2018;65:34–41.
Kim Y, et al. Prenatal exposure to phthalates and infant development at 6 months: prospective Mothers and Children’s Environmental Health (MOCEH) study. Environ Health Perspect. 2011;119(10):1495–500.
Lien YJ, et al. Prenatal exposure to phthalate esters and behavioral syndromes in children at 8 years of age: Taiwan Maternal and Infant Cohort Study. Environ Health Perspect. 2015;123(1):95–100.
Factor-Litvak P, et al. Persistent associations between maternal prenatal exposure to phthalates on child IQ at age 7 years. PLoS One. 2014;9(12):e114003.
Engel SM, et al. Prenatal phthalate exposure is associated with childhood behavior and executive functioning. Environ Health Perspect. 2010;118(4):565–71.
Engel SM, et al. Prenatal phthalates, maternal thyroid function, and risk of attention-deficit hyperactivity disorder in the Norwegian mother and child cohort. Environ Health Perspect. 2018;126(5):057004.
Wolstenholme JT, Rissman EF, Connelly JJ. The role of Bisphenol A in shaping the brain, epigenome and behavior. Horm Behav. 2011;59(3):296–305.
Rebuli ME, Patisaul HB. Assessment of sex specific endocrine disrupting effects in the prenatal and pre-pubertal rodent brain. J Steroid Biochem Mol Biol. 2016;160:148–59.
Birgersson L, et al. From cohorts to molecules: adverse impacts of endocrine disrupting mixtures. Deposited as preprint on BioRxiv 2017. https://doi.org/10.1101/206664
Miranda A, Sousa N. Maternal hormonal milieu influence on fetal brain development. Brain Behav. 2018;8(2):e00920.
Bernal J. Thyroid hormone receptors in brain development and function. Nat Clin Pract Endocrinol Metab. 2007;3(3):249–59.
Willoughby KA, McAndrews MP, Rovet JF. Effects of maternal hypothyroidism on offspring hippocampus and memory. Thyroid. 2014;24(3):576–84.
Haddow JE, et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med. 1999;341(8):549–55.
Pop VJ, et al. Low maternal free thyroxine concentrations during early pregnancy are associated with impaired psychomotor development in infancy. Clin Endocrinol (Oxf). 1999;50(2):149–55.
Korevaar TI, et al. Association of maternal thyroid function during early pregnancy with offspring IQ and brain morphology in childhood: a population-based prospective cohort study. Lancet Diabetes Endocrinol. 2016;4(1):35–43.
Ghassabian A, Trasande L. Disruption in thyroid signaling pathway: a mechanism for the effect of endocrine-disrupting chemicals on child neurodevelopment. Front Endocrinol (Lausanne). 2018;9:204.
Bowers JM, Waddell J, McCarthy MM. A developmental sex difference in hippocampal neurogenesis is mediated by endogenous oestradiol. Biol Sex Differ. 2010;1(1):8.
Luine V, Frankfurt M. Interactions between estradiol, BDNF and dendritic spines in promoting memory. Neuroscience. 2013;239:34–45.
Wang L, et al. Estrogen receptor (ER)beta knockout mice reveal a role for ERbeta in migration of cortical neurons in the developing brain. Proc Natl Acad Sci USA. 2003;100(2):703–8.
Liu SB, Zhao MG. Neuroprotective effect of estrogen: role of nonsynaptic NR2B-containing NMDA receptors. Brain Res Bull. 2013;93:27–31.
Baez MV, Cercato MC, Jerusalinsky DA. NMDA receptor subunits change after synaptic plasticity induction and learning and memory acquisition. Neural Plast. 2018;2018:5093048.
Xu X, et al. Sex-specific effects of bisphenol-A on memory and synaptic structural modification in hippocampus of adult mice. Horm Behav. 2013;63(5):766–75.
Xu XH, et al. Perinatal exposure to bisphenol-A impairs learning-memory by concomitant down-regulation of N-methyl-D-aspartate receptors of hippocampus in male offspring mice. Horm Behav. 2010;58(2):326–33.
Alavian-Ghavanini A, et al. Prenatal bisphenol A exposure is linked to epigenetic changes in glutamate receptor subunit gene Grin2b in female rats and humans. Sci Rep. 2018;8(1):11315.
Dorval KM, et al. Association of the glutamate receptor subunit gene GRIN2B with attention-deficit/hyperactivity disorder. Genes Brain Behav. 2007;6(5):444–52.
Hu C, et al. Human GRIN2B variants in neurodevelopmental disorders. J Pharmacol Sci. 2016;132(2):115–21.
Rochester JR, Bolden AL, Kwiatkowski CF. Prenatal exposure to bisphenol A and hyperactivity in children: a systematic review and meta-analysis. Environ Int. 2018;114:343–56.
Boulle F, et al. Epigenetic regulation of the BDNF gene: implications for psychiatric disorders. Mol Psychiatry. 2012;17(6):584–96.
Kundakovic M, et al. DNA methylation of BDNF as a biomarker of early-life adversity. Proc Natl Acad Sci USA. 2015;112(22):6807–13.
Holsboer F, Ising M. Stress hormone regulation: biological role and translation into therapy. Annu Rev Psychol, 2010. 61: 81–109, C1–11.
Matosin N, Halldorsdottir T, Binder EB. Understanding the molecular mechanisms underpinning gene by environment interactions in psychiatric disorders: the FKBP5 model. Biol Psychiatry. 2018;83(10):821–30.
Kitraki E, et al. Developmental exposure to bisphenol A alters expression and DNA methylation of Fkbp5, an important regulator of the stress response. Mol Cell Endocrinol. 2015;417:191–9.
Flegal KM, et al. Overweight and obesity in the United States: prevalence and trends, 1960–1994. Int J Obes Relat Metab Disord. 1998;22(1):39–47.
Hamrik Z, et al. Trends in overweight and obesity in Czech Schoolchildren from 1998 to 2014. Cent Eur J Public Health. 2017;25(Suppl 1):S10–4.
Fang M. Trends in the prevalence of diabetes among U.S. adults: 1999–2016. Am J Prev Med. 2018;55(4)
Thomas MC, et al. Evidence of an accelerating increase in prevalence of diagnosed Type 2 diabetes in British men, 1978–2005. Diabet Med. 2009;26(8):766–72.
Baillie-Hamilton PF. Chemical toxins: a hypothesis to explain the global obesity epidemic. J Altern Complement Med. 2002;8(2):185–92.
Neel BA, Sargis RM. The paradox of progress: environmental disruption of metabolism and the diabetes epidemic. Diabetes. 2011;60(7):1838–48.
Spalding KL, et al. Dynamics of fat cell turnover in humans. Nature. 2008;453(7196):783–7.
Heindel JJ, et al. Metabolism disrupting chemicals and metabolic disorders. Reprod Toxicol. 2017;68:3–33.
Braun JM, et al. Prenatal perfluoroalkyl substance exposure and child adiposity at 8 years of age: the HOME study. Obesity (Silver Spring). 2016;24(1):231–7.
Halldorsson TI, et al. Prenatal exposure to perfluorooctanoate and risk of overweight at 20 years of age: a prospective cohort study. Environ Health Perspect. 2012;120(5):668–73.
Johnson PI, et al. The Navigation Guide – evidence-based medicine meets environmental health: systematic review of human evidence for PFOA effects on fetal growth. Environ Health Perspect. 2014;122(10):1028–39.
Maisonet M, et al. Maternal concentrations of polyfluoroalkyl compounds during pregnancy and fetal and postnatal growth in British girls. Environ Health Perspect. 2012;120(10):1432–7.
Mora AM, et al. Prenatal exposure to perfluoroalkyl substances and adiposity in early and mid-childhood. Environ Health Perspect. 2017;125(3):467–73.
Lenters V, et al. Prenatal phthalate, perfluoroalkyl acid, and organochlorine exposures and term birth weight in three birth cohorts: multi-pollutant models based on elastic net regression. Environ Health Perspect. 2016;124(3):365–72.
Harley KG, et al. Prenatal and postnatal bisphenol A exposure and body mass index in childhood in the CHAMACOS cohort. Environ Health Perspect. 2013;121(4):514–20.
Vafeiadi M, et al. Association of early life exposure to bisphenol A with obesity and cardiometabolic traits in childhood. Environ Res. 2016;146:379–87.
Valvi D, et al. Prenatal bisphenol a urine concentrations and early rapid growth and overweight risk in the offspring. Epidemiology. 2013;24(6):791–9.
Hoepner LA, et al. Bisphenol A and adiposity in an inner-city birth cohort. Environ Health Perspect. 2016;124(10):1644–50.
Yang TC, et al. Bisphenol A and phthalates in utero and in childhood: association with child BMI z-score and adiposity. Environ Res. 2017;156:326–33.
Agay-Shay K, et al. Exposure to endocrine-disrupting chemicals during pregnancy and weight at 7 years of age: a multi-pollutant approach. Environ Health Perspect. 2015;123(10):1030–7.
Govarts E, et al. Birth weight and prenatal exposure to polychlorinated biphenyls (PCBs) and dichlorodiphenyldichloroethylene (DDE): a meta-analysis within 12 European Birth Cohorts. Environ Health Perspect. 2012;120(2):162–70.
Maresca MM, et al. Prenatal exposure to phthalates and childhood body size in an urban cohort. Environ Health Perspect. 2016;124(4):514–20.
Valvi D, et al. Prenatal concentrations of polychlorinated biphenyls, DDE, and DDT and overweight in children: a prospective birth cohort study. Environ Health Perspect. 2012;120(3):451–7.
Casas M, et al. Prenatal exposure to PCB-153, p,p’-DDE and birth outcomes in 9000 mother-child pairs: exposure-response relationship and effect modifiers. Environ Int. 2015;74:23–31.
Kopec G, Shekhawat PS, Mhanna MJ. Prevalence of diabetes and obesity in association with prematurity and growth restriction. Diabetes Metab Syndr Obes. 2017;10:285–95.
Alonso-Magdalena P, Quesada I, Nadal A. Prenatal exposure to BPA and offspring outcomes: the diabesogenic behavior of BPA. Dose Response. 2015;13(2):1559325815590395.
Yamamoto J, et al. Perfluorooctanoic acid binds to peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation in 3T3-L1 adipocytes. Biosci Biotechnol Biochem. 2015;79(4):636–9.
Ghanipoor-Samami M, et al. Atlas of tissue- and developmental stage specific gene expression for the bovine insulin-like growth factor (IGF) system. PLoS One. 2018;13(7):e0200466.
Kobayashi S, et al. Effects of prenatal perfluoroalkyl acid exposure on cord blood IGF2/H19 methylation and ponderal index: the Hokkaido study. J Expo Sci Environ Epidemiol. 2017;27(3):251–9.
Remy S, et al. Metabolic targets of endocrine disrupting chemicals assessed by cord blood transcriptome profiling. Reprod Toxicol. 2016;65:307–20.
Xu Y, Lopez M. Central regulation of energy metabolism by estrogens. Mol Metab. 2018;15:104–15.
Junge KM, et al. MEST mediates the impact of prenatal bisphenol A exposure on long-term body weight development. Clin Epigenetics. 2018;10:58.
Ohlstein JF, et al. Bisphenol A enhances adipogenic differentiation of human adipose stromal/stem cells. J Mol Endocrinol. 2014;53(3):345–53.
Dong H, et al. Non-cytotoxic nanomolar concentrations of bisphenol A induce human mesenchymal stem cell adipogenesis and osteogenesis. Ecotoxicol Environ Saf. 2018;164:448–54.
Takahashi M, Kamei Y, Ezaki O. Mest/Peg1 imprinted gene enlarges adipocytes and is a marker of adipocyte size. Am J Physiol Endocrinol Metab. 2005;288(1):E117–24.
Taylor JA, et al. Prenatal exposure to bisphenol A disrupts naturally occurring bimodal DNA methylation at proximal promoter of fggy, an obesity-relevant gene encoding a carbohydrate kinase, in Gonadal White Adipose Tissues of CD-1 mice. Endocrinology. 2018;159(2):779–94.
Wei J, et al. Perinatal exposure to bisphenol A at reference dose predisposes offspring to metabolic syndrome in adult rats on a high-fat diet. Endocrinology. 2011;152(8):3049–61.
Mackay H, et al. Organizational effects of perinatal exposure to bisphenol-A and diethylstilbestrol on arcuate nucleus circuitry controlling food intake and energy expenditure in male and female CD-1 mice. Endocrinology. 2013;154(4):1465–75.
Angle BM, et al. Metabolic disruption in male mice due to fetal exposure to low but not high doses of bisphenol A (BPA): evidence for effects on body weight, food intake, adipocytes, leptin, adiponectin, insulin and glucose regulation. Reprod Toxicol. 2013;42:256–68.
Huo D, et al. Incidence rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix: update after 40-year follow-up. Gynecol Oncol. 2017;146(3):566–71.
Hilakivi-Clarke L. Maternal exposure to diethylstilbestrol during pregnancy and increased breast cancer risk in daughters. Breast Cancer Res. 2014;16(2):208.
Troisi R, et al. Medical conditions among adult offspring prenatally exposed to diethylstilbestrol. Epidemiology. 2013;24(3):430–8.
Stelmach I, et al. The effect of prenatal exposure to phthalates on food allergy and early eczema in inner-city children. Allergy Asthma Proc. 2015;36(4):72–8.
Buckley JP, et al. Associations of prenatal environmental phenol and phthalate biomarkers with respiratory and allergic diseases among children aged 6 and 7years. Environ Int. 2018;115:79–88.
Jahreis S, et al. Maternal phthalate exposure promotes allergic airway inflammation over 2 generations through epigenetic modifications. J Allergy Clin Immunol. 2018;141(2):741–53.
Gascon M, et al. Prenatal exposure to bisphenol A and phthalates and childhood respiratory tract infections and allergy. J Allergy Clin Immunol. 2015;135(2):370–8.
Shu H, et al. PVC flooring at home and development of asthma among young children in Sweden, a 10-year follow-up. Indoor Air. 2014;24(3):227–35.
Attina TM, et al. Exposure to endocrine-disrupting chemicals in the USA: a population-based disease burden and cost analysis. Lancet Diabetes Endocrinol. 2016;4(12):996–1003.
Legler J, et al. Obesity, diabetes, and associated costs of exposure to endocrine-disrupting chemicals in the European Union. J Clin Endocrinol Metab. 2015;100(4):1278–88.
Trasande L, et al. Burden of disease and costs of exposure to endocrine disrupting chemicals in the European Union: an updated analysis. Andrology. 2016;4(4):565–72.
Liew Z, et al. Prenatal exposure to perfluoroalkyl substances and IQ scores at age 5; a study in the Danish National Birth Cohort. Environ Health Perspect. 2018;126(6):067004.
Carlsen E, et al. Evidence for decreasing quality of semen during past 50 years. BMJ. 1992;305(6854):609–13.
Weintraub K. The prevalence puzzle: autism counts. Nature. 2011;479:22–4.
Demeneix B. Losing our minds: how environmental pollution impairs human intelligence and mental health (Oxford Series in Behavioral Neuroendocrinology). 1 ed. 2014: Oxford University Press.
OECD. Overweight or obese population (indicator). 05 September 2018.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Engdahl, E., Rüegg, J. (2020). Prenatal Exposure to Endocrine Disrupting Chemicals and Their Effect on Health Later in Life. In: Teperino, R. (eds) Beyond Our Genes. Springer, Cham. https://doi.org/10.1007/978-3-030-35213-4_4
Download citation
DOI: https://doi.org/10.1007/978-3-030-35213-4_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-35212-7
Online ISBN: 978-3-030-35213-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)